Abstract
MicroRNAs can influence hematopoietic cell lineage commitment and aberrant expression of hematopoietic miRNAs contributes to AML pathology. We found that miR-143 and miR-145 expression is significantly repressed in primary AML patient samples as compared to neutrophils of healthy donors. Further analysis revealed impaired neutrophil differentiation of APL cells upon inhibition of miR-145 expression. Lastly, we identified p73 as transcriptional regulator of miR-143/145 during neutrophil differentiation of APL cells. Our data suggest that low miR-145 levels in APL, possibly due to aberrant expression of p73 transcription factors, contribute to the differentiation block seen in this disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / pharmacology
-
Cell Differentiation*
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / metabolism
-
Gene Expression Regulation, Neoplastic*
-
Humans
-
Leukemia, Myeloid, Acute / genetics*
-
MicroRNAs / antagonists & inhibitors
-
MicroRNAs / genetics*
-
Neutrophils / metabolism
-
Neutrophils / pathology*
-
Nuclear Proteins / genetics
-
Nuclear Proteins / metabolism
-
Promoter Regions, Genetic / genetics
-
Real-Time Polymerase Chain Reaction
-
Tretinoin / pharmacology
-
Tumor Cells, Cultured
-
Tumor Protein p73
-
Tumor Suppressor Proteins / genetics
-
Tumor Suppressor Proteins / metabolism
Substances
-
Antineoplastic Agents
-
DNA-Binding Proteins
-
MIRN143 microRNA, human
-
MIRN145 microRNA, human
-
MicroRNAs
-
Nuclear Proteins
-
TP73 protein, human
-
Tumor Protein p73
-
Tumor Suppressor Proteins
-
Tretinoin